oral microdose glp 1 GLP-1 microdosing is popular, but there's little evidence it works Does Microdosing Ozempic or Other

A review of 30 randomized controlled trials that included 1,736 people with type 2 diabetes or non-alcoholic fatty liver disease found that treatment with GLP-1 agonists significantly reduced both visceral and liver fat

After 26 weeks of tirzepatide treatment at different doses, several biomarkers associated with inflammation were reduced

Hope DCD, Hinds CE, Lopes T, Vincent ML, Shrewsbury JV, Yu ATC, et al

Br J Clin Pharmacol (2019) 85:271420

2: Reduction in Certain Diseases Recent clinical trial results suggest that the health impacts of GLP-1RAs go beyond weight loss, with the drug leading to a reduction in various diseases, such as cardiovascular disease or slowing down the progression of some illnesses such as chronic kidney disease

Ozempic is commonly prescribed to patients for the treatment of type 2 diabetes and has also demonstrated effectiveness in supporting healthy weight management